3048SP |
Metribuzin, Serum/Plasma |
3055B |
Mexiletine, Blood |
3055SP |
Mexiletine, Serum/Plasma |
3064B |
Mitragynine, Blood |
3064SP |
Mitragynine, Serum/Plasma |
3078U |
Mitragynine (Qualitative), Urine |
3092SP |
Moricizine, Serum/Plasma |
3168B |
Nitazenes Panel, Blood |
3218B |
N,N-Dimethylpentylone & Pentylone, Blood |
3218SP |
N,N-Dimethylpentylone & Pentylone, Serum/Plasma |
3218U |
N,N-Dimethylpentylone & Pentylone, Urine |
3224B |
NPS Stimulants (Qualitative), Blood |
3224SP |
NPS Stimulants (Qualitative), Serum/Plasma |
3224U |
NPS Stimulants (Qualitative), Urine |
3227B |
Beta-Blockers Panel, Blood |
3227SP |
Beta-Blockers Panel, Serum/Plasma |
3227U |
Beta-Blockers Panel, Urine |
3325B |
Paraquat, Blood |
3325SP |
Paraquat, Serum/Plasma |
3426B |
Perfluorooctanoic Acid, Blood Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3427SP |
Perfluoroalkyl Substances (PFAS), Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3428SP |
PFASure TM, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3429SP |
PFASure TM Expanded, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3976B |
Propafenone, Blood |
3976SP |
Propafenone, Serum/Plasma |